根据最终合并协议,Viewpoint的每一股已发行和流通股份将转换为获得Isoray 3.3212股的权利。Viewpoint股东将拥有Isoray完全稀释的流通股49%的股份。
$华海药业(SH600521)$ $华东医药(SZ000963...查看全文
$Isoray(ISR)$ SD - Filed: 2019-05-10 AccNo: 0001437749-19-009513 Size: 17 KB 网页链接
$Isoray(ISR)$ 8-K - Current report Filed: 2019-05-09 AccNo: 0001437749-19-009299 Size: 193 KBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Isoray(ISR)$ 美东时间 2019-05-09 盘后 披露财报,预期EPS -0.02 网页链接
$Isoray(ISR)$ 8-K - Current report Filed: 2019-05-02 AccNo: 0001437749-19-008606 Size: 333 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Isoray(ISR)$ 8-K - Current report Filed: 2019-03-04 AccNo: 0001437749-19-003869 Size: 5 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Isoray(ISR)$ CT ORDER - Confidential treatment order Filed: 2019-02-26 AccNo: 9999999997-19-000577 Size: 105 KB 网页链接
$Isoray(ISR)$ 8-K - Current report Filed: 2019-02-19 AccNo: 0001437749-19-002868 Size: 19 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Isoray(ISR)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-02-14 AccNo: 0001437749-19-002647 Size: 664 KB 网页链接
$Isoray(ISR)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-02-13 AccNo: 0001437749-19-002356 Size: 3 MB 网页链接
$Isoray(ISR)$ 8-K - Current report Filed: 2019-02-12 AccNo: 0001437749-19-002332 Size: 264 KBItem 1.01: Entry into a Material Definitive AgreementItem 1.02: Termination of a Material Definitive AgreementItem 2.02: Results of Operations and Financial ConditionItem 5.02: Depart...